Progress Of Gastrointestinal Neoplasms and Therapeutic Advances

In recent times, there has been a notable rise in the incidence of gastrointestinal neoplasms due to changes in diet and lifestyle. When it comes to cancer-related deaths in males under 50, colorectal cancer ranks first, and in women, it is second. Gastric cancer and colorectal cancer are the two main types of intestinal neoplasms. Among East Asian populations, gastric cancer has the highest incidence rates. Studies reveal a critical role for gastrointestinal microecology in the development and course of gastrointestinal tumors. In addition to providing a brief overview of the pathophysiology and standard treatments for stomach tumors, this paper addresses the state of research regarding the connection between gastrointestinal microecology and immunological treatment of stomach tumors. The process by which gastric cancer develops is complex and involves variations in growth patterns, mucus separation, cellular structure, and genetic makeup. Microecological imbalances, genetic factors, and poor dietary practices are major causes of gastric cancer. Chemotherapy, surgery, radiation therapy, and targeted therapies are among the current treatment options. Immune checkpoint antagonists, combination immunotherapy, and adoptive immune-mediated cell therapy have all shown notable effectiveness in clinical practice. However, immunotherapy still faces obstacles from immune-related side effects and treatment resistance. Subsequent investigations will probe further into the correlation between gastrointestinal microecology and gastrointestinal tumors, presenting novel approaches to the management and avoidance of gastrointestinal neoplasms.